In particular, Waning et al. previously suggested that enhanced bone resorption associated with cancer dissemination results in release of TGFβ from the bone matrix, which in turn causes modulation of muscle regulatory pathways and contributes to muscle weakness (19). This evidence concerns the gene TGFB1 and cancer.